TriSalus Life Sciences (NASDAQ:TLSIW) Stock Price Up 2.3% – Time to Buy?

TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) shares rose 2.3% during trading on Friday . The company traded as high as $1.20 and last traded at $0.90. 9,780 shares traded hands during mid-day trading, an increase of 87% from the average daily volume of 5,236 shares. The stock had previously closed at $0.8798.

TriSalus Life Sciences Stock Performance

The stock has a 50-day moving average price of $0.73 and a two-hundred day moving average price of $1.10.

Hedge Funds Weigh In On TriSalus Life Sciences

Large investors have recently added to or reduced their stakes in the company. Cerity Partners LLC purchased a new position in shares of TriSalus Life Sciences during the 4th quarter valued at $1,374,000. Citadel Advisors LLC increased its stake in TriSalus Life Sciences by 439.0% in the 3rd quarter. Citadel Advisors LLC now owns 126,876 shares of the company’s stock worth $199,000 after buying an additional 103,336 shares in the last quarter. Aristeia Capital L.L.C. bought a new stake in TriSalus Life Sciences during the fourth quarter valued at about $43,000. Finally, Fort Baker Capital Management LP purchased a new stake in shares of TriSalus Life Sciences during the fourth quarter worth about $44,000.

About TriSalus Life Sciences

TriSalus Life Sciences, Inc is a clinical-stage medical device company focused on developing minimally invasive technologies to enhance the precision and efficacy of cancer radiation therapy. The company’s lead product, the TriMark™ Tissue Marker System, is designed to provide high-visibility soft-tissue fiducial markers that assist oncologists in accurately targeting tumors during radiotherapy. By deploying bio-absorbable markers directly into tumor beds, TriSalus aims to improve treatment planning, patient comfort and long-term follow-up imaging.

Founded in 2015 and headquartered in Plymouth, Minnesota, TriSalus Life Sciences pursues a platform approach to oncology treatment, with research and development efforts centered on novel delivery devices and advanced imaging solutions.